Comedian Amy Schumer shared a series of no-filter bikini photos on Instagram over the weekend, capping a health journey that included failed rounds of Ozempic and Wegovy, a Cushing syndrome diagnosis, and a switch to Mounjaro and hormone therapy.

Schumer, 45, posed in a colorful two-piece swimsuit by the water and captioned the post: "I never knew there would be days like this. No filter as per ushe." The photos drew immediate praise from fellow celebrities, with actress Kate Walsh commenting, "So beautiful, Amy. Happy and thriving." Comedian Anjelah Johnson and actress Isla Fisher also weighed in with enthusiastic responses.

The bikini post is the latest chapter in a multi-year public reckoning with her body, her health, and the booming weight-loss drug industry, one Schumer has narrated with more candor than most Hollywood figures typically offer.

Ozempic left her bedridden; Mounjaro changed the equation

Schumer's path to the weekend photos was not smooth. Roughly three years ago, she tried Wegovy and described the experience bluntly in a March 2025 Instagram video recorded from behind the wheel of her car.

Fox News Digital reported that Schumer told her nearly 13 million Instagram followers:

"I wanted to share and keep it 100 with you, that years ago, and yes, this is completely unsafe to be driving and making a video, years ago, three years ago, I tried Wegovy and I was like puking."

She also tried Ozempic around the same time. During an appearance on "The Howard Stern Show," she explained that a gene called GDF15 makes her extremely prone to nausea, the same gene that made her pregnancy miserable.

"I lost 30 pounds so quick. I looked great, and I couldn't lift my head off the pillow, so what's the point?"

That blunt cost-benefit analysis, look great but feel terrible, captures a tension millions of Americans now face as GLP-1 drugs reshape the weight-loss landscape. Schumer eventually found a drug that worked for her: Mounjaro, the brand name for tirzepatide. She obtained it through a telehealth consultation with MidiHealth, a company she described as "cheap," and said she wanted to try the medication herself before recommending it to friends who work as nurses and teachers.

In the same video, Schumer disclosed that MidiHealth also put her on estrogen and progesterone after she realized she was in perimenopause. She credited the hormone therapy with eliminating her perimenopause symptoms. In a culture where celebrities routinely deny any pharmaceutical assistance, Schumer's willingness to name the drugs, the provider, and the side effects stands out, whatever one thinks of the choices themselves.

Cushing syndrome, a hysterectomy, and a string of health setbacks

The weight-loss drugs were only part of a longer medical history Schumer has made public. In 2021, she underwent a hysterectomy after living with endometriosis. Then in February 2024, after fans questioned swelling in her face, she revealed a diagnosis of Cushing syndrome, a hormonal disorder that can cause weight gain, facial puffiness, and a range of other symptoms.

Schumer said she viewed the Cushing diagnosis as a blessing because it led doctors to uncover the underlying cause, though the specific cause was not publicly disclosed. The diagnosis added medical context to appearance changes that social media commenters had already seized on, and it underscored how quickly the public rushes to judge a woman's body without knowing the full story.

Hollywood's relationship with weight-loss transparency remains deeply dishonest. Schumer herself has addressed this directly. The New York Post noted that Schumer previously called out the double standard, saying: "Everybody's lying... Be real with the people. When I got lipo, I said I got lipo." That willingness to name what she has done, liposuction, Ozempic, Wegovy, Mounjaro, hormone therapy, puts her in a small minority among public figures who profit from their appearance.

The entertainment industry's culture of secrecy around cosmetic and pharmaceutical interventions is its own form of dishonesty, one that sets impossible standards for ordinary people. Whether Schumer's candor is admirable or simply good personal branding, it at least gives her audience real information, a low bar that most of her peers still fail to clear.

A "dramatic transformation" and a personal split preceded the bikini post

The weekend photos were not Schumer's first public display of her changed physique. In October, she posted a photo showing what the coverage described as a "dramatic transformation", wearing a small black dress and heels at a Paul McCartney concert in Las Vegas with two friends. That post also drew celebrity praise.

Earlier, she had shared a mirror selfie on Instagram Stories in a sports bra, showing a flat stomach and captioning it: "No filter, no filler, no clean mirror." The pattern is consistent: Schumer documents her body publicly, names the interventions, and invites both praise and scrutiny. It is a strategy that generates attention, but it also provides a degree of accountability rare in celebrity culture.

Behind the public health journey, Schumer's personal life also shifted. Fox News reported that Schumer announced her split from husband Chris Fischer after seven years of marriage in December 2024. The couple share a son, Gene, who is four years old. Schumer framed the new year as a reset, writing on Instagram: "This year is about self care and self love. No makeup. No filter... Moving forward with no regrets. Just love."

Actress Courteney Cox responded to that post with "You are gorgeous Amy," adding to the chorus of celebrity support that has followed Schumer's public disclosures. The consistent thread in the reactions, from Walsh, Johnson, Fisher, and Cox, is praise for openness rather than for any particular look.

In a media environment where behind-the-scenes power plays and carefully managed images are the norm, Schumer's approach is at least different. Whether it reflects genuine transparency or a savvy understanding of what sells in the age of GLP-1 drugs is a question only she can answer.

GLP-1 drugs and the honesty gap in public life

Schumer's story lands at a moment when millions of Americans are navigating the same questions she has, which weight-loss drug to try, what the side effects are, whether insurance or telehealth can make them affordable, and how much to tell the people around them. The difference is that most people making those decisions do not have 13 million followers watching.

The broader cultural debate around Ozempic, Wegovy, and Mounjaro has exposed a familiar pattern: public figures benefit from pharmaceutical interventions and then deny or obscure what they have done. That dishonesty is not limited to Hollywood. Politicians, media figures, and public officials routinely present managed images while internal contradictions go unaddressed.

Schumer's medical history, the GDF15 gene, the Cushing syndrome, the endometriosis, the hysterectomy, the failed drug trials, is genuinely complicated. It does not fit a neat before-and-after narrative. And her willingness to share that complexity, including the parts that are unflattering or messy, offers a contrast to the polished fiction most public figures prefer.

Several open questions remain. Schumer has not publicly confirmed whether she is still taking Mounjaro. The specific underlying cause of her Cushing syndrome has not been disclosed. And the long-term effects of combining GLP-1 drugs with hormone replacement therapy are still being studied across the medical community.

None of that diminishes the basic fact that Schumer told the public what she was taking, how it made her feel, and what went wrong before something went right. In a culture that rewards dishonesty about bodies, money, and power, even partial honesty stands out against a backdrop where accountability is increasingly rare.

Americans deserve straight answers from the people who shape public conversation, whether those people hold office or hold a microphone. Schumer, whatever her politics, at least gave hers.